SmarTrend identified a Downtrend for Viropharma (NASDAQ:VPHM) on October 26th, 2012 at $26.57. In approximately 2 months, Viropharma has returned 16.30% as of today's recent price of $22.24.

In the past 52 weeks, shares of Viropharma have traded between a low of $19.02 and a high of $33.17 and are now at $22.38, which is 18% above that low price. Over the past week, the 200-day moving average (MA) has gone down 0.6% while the 50-day MA has declined 2%.

ViroPharma Incorporated is a biopharmaceutical company committed to the commercialization, development, and discovery of new medicines. The Company's products include a treatment for prophylaxis of hereditary angioedema as well a capsules for the treatment of antibiotic associated pseudomembranous colitis caused by Clostridium difficile infection (CDI) and enterocolitis.

SmarTrend will continue to scan these moving averages and a number of other proprietary indicators for any changes in momentum for shares of Viropharma.

Log in and add Viropharma (VPHM) to your watchlist today so you can receive a real-time alert when the shares are about to change trend.